CaaMTech is pioneering next-generation #psychedelic drugs for the 21st century.
Joined December 2019
- Tweets 167
- Following 117
- Followers 446
- Likes 246
1 Photos and videos
Pinned Tweet
18 Jan 2022
Thank you @FastCompany for highlighting our important work in #psychedelics as a part of "15 tech startups to watch in 2022." 👨🔬🧪
Read @thesullivan's piece here: fastcompany.com/90710812/15-…
1
2
8
14 Nov 2024
CaaMTech’s new clinical trial design solves the emergent functional unblinding problems plaguing #psychedelic medicine developers caam.tech/fda-blesses-caamte…
1
135
21 Sep 2023
Scientists at @LeibnizHKI, working in collaboration with CaaMTech, recently reported new results investigating terpene-producing enzymes in “magic” mushrooms. caam.tech/caamtech-collabora…
1
5
382
CaaMTech retweeted
14 Sep 2023
A "Magic Mushroom" Multi-Product Sesquiterpene Synthase (Dirk Hoffmeister and co-workers) @OConnor_lab, @MPI_ICE, @UniJena, @LeibnizHKI, @microverse_exc, @CaaMTechInc #OpenAccess onlinelibrary.wiley.com/doi/…
3
18
4,554
14 Sep 2023
@CaaMTechInc CEO, Dr. Andrew Chadeayne, will give two presentations at the 2023 Rocky Mountain Regional Meeting of the American Chemical Society on September 16th caam.tech/caamtech-ceo-to-pr…
94
12 Sep 2023
The publication of the crystal structure of 4-AcO-EPT fumarate fumaric acid also exemplifies @CaaMTechInc's pioneering #tryptamine prodrug and SAR research caam.tech/caamtech-crystallo…
1
284
4 Aug 2023
Dialkyl #tryptamines have received widespread attention for their potential to treat numerous mood disorders. But secondary tryptamines, or monoalkyl tryptamines, have received almost no such attention. caam.tech/caamtech-and-unive…
1
1
238
CaaMTech retweeted
4 Apr 2023
In my opinion, @CaaMTechInc is one of the most interesting startups to watch in the #psychedelics space. To learn more about what they're doing, check out my conversation with founder/CEO @AndrewChadeayne: mindandmatter.substack.com/p…
4
6
1,707
28 Mar 2023
@CaaMTechInc, through its CRADA with DDRU @NIDAnews IRP (part of @NIH) and in collab with scientists from the Manke Lab at @UMassD recently published receptor binding and HTR data for the synthetic #psilocybin analog 4-PrO-DMT and related tryptamines
caam.tech/foundational-scien…
174
14 Mar 2023
CaaMTech Synthesizes and Characterizes Monoalkyl Tryptamine 4-HO-NiPT
The research lays the groundwork for the pharmacological study of monoalkyl tryptamine analogues of relatively well-characterized dialkyl tryptamines such as psilocybin and psilocin.
caam.tech/caamtech-synthesiz…
1
2
210
CaaMTech retweeted
8 Nov 2022
Structure–Activity Relationships for Psilocybin, Baeocystin, Aeruginascin, and Related Analogues to Produce Pharmacological Effects in Mice: loom.ly/-26TjX4
3
8
15 Nov 2022
Psilacetin is More Potent than Psilocybin:
@CaaMTechInc, @NIDAnews, @usonainstitute, @ResearchUGent, @UMassD and @UWyonews researchers directly compared #psilocybin with understudied #magicmushroom molecules, and synthetic analogs such as psilacetin
caam.tech/psilacetin-is-more…
3
7
CaaMTech retweeted
2 Nov 2022
This was truly an amazing team effort by many folks from @usonainstitute, @CaaMTechInc, @christophestove, Manke lab, Hulley lab, and NIDA IRP DDRU.
Keep an eye out for many more publications from us investigating the #pharmacology of #psychedelics !
1
2
6
CaaMTech retweeted
27 Oct 2022
My most downloaded podcast episode on @substack this year was with organic chemist & @CaaMTechInc CEO @AndrewChadeayne.
It's basically a deep dive into topics related to chemistry & pharmacology of psychedelic tryptamines.
Listen here: mindandmatter.substack.com/p…
2
3
22 Sep 2022
New paper by @CaaMTechInc @marilyn_naeem @BarbBauerCT @UMassD @AndrewChadeayne! 4-HO-DiPT has been proposed as a more clinically-optimized alternative to #psilocybin
#psychedelic #science #chemistry #crystallography
caam.tech/caamtech-creates-t…
1
3
9
14 Sep 2022
“Two years ago, no one appreciated that aeruginascin was present in magic mushrooms,” explained CaaMTech CEO, Dr. Andrew Chadeayne.
caam.tech/caamtech-publishes…
CaaMTech retweeted
26 Aug 2022
DEA Abandons Proposal To Ban Two More Psychedelics After Being Challenged By Scientists
"In April, the agency published a notice of its intent to place the hallucinogens DOI and DOC in Schedule I of the Controlled Substances Act"
marijuanamoment.net/dea-aban…
1
2
5
CaaMTech retweeted
22 Jul 2022
BREAKING: DEA Withdraws Proposal to Schedule 5 Psychedelic Tryptamines
The challenge was led by co-counsel Matt Zorn and @calyxlaw for @TactogenInc and @MindstateDesign, with many others involved.
This is a remarkable and unprecedented outcome.
22 Jul 2022
5 psychedelic tryptamines, kept off schedule I?
DEA scheduling proceedings—terminated:
“DEA is withdrawing the proposed rule…canceling the public hearing & terminating the pending hearing proceedings”
Unprecedented outcome—a result of extraordinary lawyering by Matt Zorn
1/2
3
21
59
CaaMTech retweeted
6 Jul 2022
A DEA scheduling hearing on 5 psychedelic tryptamines?
4-HO-DiPT, 5-MeO-AMT, 5-MeO-MiPT, 5-MeO-DET, & DiPT
“all have a high potential for abuse, no currently accepted medical use in treatment in the US, & a lack of accepted safety for use”
Notice published today
1/2
5 Jul 2022
A DEA scheduling hearing on five psychedelic tryptamines?
Notice to be published tomorrow, announcing Aug 22 hearing on proposed scheduling of 4-HO-DiPT, 5-MeO-AMT, 5-MeO-MiPT, 5-MeO-DET, & DiPT
Matt Zorn: “get your popcorn ready”
@kylejaeger for @MarijuanaMoment:
2
1
6
CaaMTech retweeted
19 Jul 2022
▶️ Synthesis, Structural Characterization, and Pharmacological Activity of Novel Quaternary Salts of 4-Substituted Tryptamines
👥 Grant C. Glatfelter, David R. Manke & coworkers
go.acs.org/1H7
@UMassD @NIDAnews @CaaMTechInc #Pharmaceuticals #SAR #CNS
ALT Synthesis, Structural Characterization, and Pharmacological Activity of Novel Quaternary Salts of 4-Substituted Tryptamines
2
6
